Literature DB >> 7912295

Microalbuminuria and endothelial dysfunction in essential hypertension.

R Pedrinelli1, O Giampietro, F Carmassi, E Melillo, G Dell'Omo, G Catapano, E Matteucci, L Talarico, M Morale, F De Negri.   

Abstract

Microalbuminuria (urinary albumin excretion between 20 and 200 micrograms/min) and endothelial dysfunction coexist in patients with essential hypertension. To evaluate whether the two phenomena are related and the determinants of that association, we recruited 10 untreated males with essential hypertension and microalbuminuria without diabetes to be compared with an equal number of matched patients with essential hypertension excreting albumin in normal amounts and 10 normal controls. The status of endothelial function was inferred from circulating von Willebrand Factor antigen (vWF), a glycoprotein secreted in greater amounts when the vascular endothelium is damaged. vWF concentrations were higher in hypertensive patients with microalbuminuria than in hypertensive patients without and controls. Individual vWF and urine albumin-excretion values were correlated (r = 0.55, p < 0.002). Blood pressure correlated with both urinary albumin excretion and vWF. Left ventricular mass index and minimal forearm vascular resistances were comparable in patients with hypertension and higher than in controls; total and low-density lipoprotein cholesterol, triglycerides, lipoprotein-a, Factor VII, and plasminogen activator inhibitor-1 did not differ. Fibrinogen was higher and creatinine clearance lower in microalbuminurics. Albuminuria in essential hypertension may reflect systemic dysfunction of the vascular endothelium, a structure intimately involved in permeability, haemostasis, fibrinolysis, and blood pressure control. This abnormality may have important physiopathological implications and expose these patients to increased cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912295     DOI: 10.1016/s0140-6736(94)91047-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  57 in total

1.  Characterization of von Willebrand factor in primary pulmonary hypertension.

Authors:  M T Collados; J Sandoval; S López; F A Massó; A Páez; J R Borbolla; L F Montaño
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis.

Authors:  Jennifer A Nettleton; Lyn M Steffen; Walter Palmas; Gregory L Burke; David R Jacobs
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

3.  Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH.

Authors:  Christian Ukena; F Mahfoud; M Kindermann; S Gräber; I Kindermann; M Schneider; R Schmieder; P Bramlage; M Volpe; M Thoenes; M Böhm
Journal:  Clin Res Cardiol       Date:  2010-07-11       Impact factor: 5.460

Review 4.  Microalbuminuria in primary hypertension: a guide to optimal patient management?

Authors:  Francesca Viazzi; Francesca Cappadona; Roberto Pontremoli
Journal:  J Nephrol       Date:  2016-07-14       Impact factor: 3.902

5.  Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Noriyuki Ohkura; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Kiyoki Kitagawa; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-12-15       Impact factor: 2.801

6.  Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.

Authors:  Dimitrios Daoussis; Vasileios F Panoulas; Holly John; Tracey E Toms; Ioannis Antonopoulos; Gareth Treharne; Peter Nightingale; Karen M J Douglas; George D Kitas
Journal:  Clin Rheumatol       Date:  2010-04-16       Impact factor: 2.980

Review 7.  New concepts regarding events that lead to myocardial infarction.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

8.  Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.

Authors:  F I Parthenakis; M E Marketou; J E Kontaraki; F Maragoudakis; S Maragkoudakis; H Nakou; K Roufas; A Patrianakos; G Chlouverakis; N Malliaraki; P E Vardas
Journal:  J Hum Hypertens       Date:  2016-03-17       Impact factor: 3.012

9.  Heart rate variability predicts ESRD and CKD-related hospitalization.

Authors:  Daniel J Brotman; Lori D Bash; Rehan Qayyum; Deidra Crews; Eric A Whitsel; Brad C Astor; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

Review 10.  Does the addition of fibrates to statin therapy have a favorable risk to benefit ratio?

Authors:  Eliot A Brinton
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.